You are on page 1of 4

Dims cute

BSN-2F

NCM 106 – Anti-infective agent 4. Interfere with the DNA


synthesis in the cell.
- Are drugs designed to target foreign
5. Alter permeability of the cell
organisms that have invaded and
membrane to allow essential
infected the body of a human host.
cellular components to leak.
- Use of drugs to treat systemic
 Anti-infective Activity:
infection is an actively new concept,
- Vary in their spectrum of activity;
beginning with Paul Ehrlich in the
that is, they vary in their
1920s
effectiveness against invading
- His research to develop a synthetic
organisms.
chemical that would be effective only
- 2 types of Spectrum:
against infection-causing cells, not
1. Narrow spectrum – selective
human cells, led the way to for the
in their action that they are
scientific investigation of anti-
only effective against only a
infective agent.
few microorganisms.
- In 1920s penicillin was discovered
2. Broad spectrum – interfere
- 1935 the sulfonamides were
with their biochemical
introduced.
reaction in many kinds of
- Although it targets foreign
microorganism, making them
substance, it does not possess total
useful in treatment of a wide
selective toxicity, which is the ability
variety of infection.
certain protein and enzymes
- Several drugs are “cidal” and
systems used only by the infecting
“static”, depending on the
organism, but not by human cells.
concentration on the drug present.
 Therapeutic action
 Bactericidal – so active
- An act of attacking the invading
against invading
organism.
microorganism that they
- Goal: is to interfere with the normal
cause death of the cell they
functioning of the invading organism
affect.
to prevent from reproducing and to
 Bacteriostatic – not
cause death cell without affecting
aggressive, and they
the host.
interfere the ability of the cell
- Specific mechanism:
to reproduce.
1. Interfere with biosynthesis of
 Human Immune Response:
the pathogen wall. Since
- The goal of anti-infectives is to
bacterial cell has different
reduce the amount of foreign
composition from the human
substance in the body where the
cell
immune response can work on its
2. Prevent the invading cells
own.
using substance essential to
- If drug is aggressive enough, it might
their growth and
be toxic to the body.
development, leading to the
- It involves complex interaction
inability to divide and cause
among:
cell death.
1. Chemical mediators
3. Interfere with the protein
2. Leukocytes
synthesis
3. Lymphocytes
4. Antibodies
Dims cute
BSN-2F

5. Locally released enzymes altering the transport system


- When this response is completely to exclude the drug.
functional, and all necessary 3. Altering binding site on the
materials can be produced then it membrane – no longer
can isolate and eliminate the foreign accept the drug.
bodies. 4. Producing chemical – that
- Person who is immunocompromised acts as an antagonist to the
– the immune system may be drug.
incapable of eliminating the foreign - Other microbes may develop
substance. resistance through genetic mutation.
- It is difficult to treat patient with such  Preventing resistance
immune system because: - Drug dosage – is important in
1. Anti-infective agent cannot preventing the development of
eliminate the pathogen resistance. Doses should be high
without causing severe enough and duration of drug therapy
toxicity in the host. should be long enough to eradicate
2. This patient does not have even slightly of microorganism.
the inflammatory or immune - Duration of drug use – is critical to
response in place to deal ensure that the microbes are
with few invading organisms. eliminated and no chance of
 Resistance growing. And develop resistance
- Can be natural or acquired and strain.
refers to the ability over time to  Using of anti-infective agent:
adapt to an anti-infective drug and - Anti-infective agent is used to treat
produce cells that are no longer systemic infection and sometimes as
affected by a drug. means of prophylaxis.
- This is because anti-infective drug  Treatment of system infection:
acts on a specific enzymes system 1. Identification of the
or biological processes and many pathogen:
microorganisms that do not use this - Is an important first step in
system are not affected by anti- determining which anti-infective drug
infective drug and have some should be used.
natural resistance. - Is done by culturing a tissue sample
- Some microorganisms that was from the infected area.
sensitive to the drug would acquire - Cultures – are performed in a
resistance to the agents. This can laboratory, in which a swab of
result to serious problem. infected tissue can grow on an agar
 Acquiring resistance: plate.
- Developed resistance in several - Staining technique and microscopic
ways: examination are used to identify the
1. Producing an enzyme – that offending bacterium.
deactivates the antimicrobial 2. Sensitivity to the pathogen
drug. - Sensitivity testing – it is important to
2. Changing cellular perform this test to evaluate bacteria
permeability – to prevent and determine which drugs can
drug from entering the cell or control the microorganism.
Dims cute
BSN-2F

- Important with microorganism with kidney and then eliminated in


resistance strain. the urine.
- Culture and sensitivity testing – both - Such drug as direct toxic effect on
identify the causal pathogens and the fragile cells in the kidney, can
the most appropriate drug for cause conditions ranging from renal
treating the infection. dysfunction to full-blown renal
3. Combination therapy failure.
- Combination of two or more types of 2. GI tract – are very common
drug effectively treats the infection. with many anti-infective,
- Combination drugs – maybe many of these agents have
effective in interfering with its cellular direct toxic effect on the cell
structure in different areas of lining of GI tract.
developmental phase. - It causes:
- Several reasons that combination  Nausea
therapy can be used:  Vomiting
 Health care provider may be  Stomach upset
encouraged to use a smaller  Diarrhea
dose of each drug, leading to 3. Nervous
fewer adverse effects but still system/neurotoxicity –
having a therapeutic impact some anti-infectives can
 Some drugs are synergistic – damage or interfere with the
which means they are more function of nerve tissue,
powerful when given in usually in areas where drugs
combination. tend to accumulate in high
 Many microbial infections are concentration
caused by more than one - Example: Aminoglycoside – collect
organism, and each in the eight cranial nerve and can
pathogen may react to a cause:
different anti-infective agent.  Dizziness
 Sometimes, combined  Vertigo
effects of the different drugs  Loss of hearing
delay the emergence of 4. Hypersensitivity –
resistant strains. reportedly occur with many
 Prophylaxis antimicrobial agents.
- Prevention of specific disease before - Most of these agents, which are
they occur. protein bound for transfer through
 Adverse reactions to anti-infective the cardiovascular system, can
therapy induce antibody formulation in
- There are no anti-infective drugs that susceptible people.
do not have adverse effect, it will 5. Superinfection – are
always have an effect on the body infections that occur when
once taken. opportunistic pathogens that
- Commonly adverse effect: were kept in check by the
1. Kidney damage – occurs “normal” floral bacteria can
most frequently with drugs invade tissues.
that are metabolized by the - Common superinfections include:
1. Vaginal
Dims cute
BSN-2F

2. GI yeast infection
- Caused by proteus and
pseudomonas throughout the body.

You might also like